David Zhang

Interactive Q&A: Daniel Montano, Chairman, President and CEO of CardioVascular BioTherapeutics Inc. (CVBT.OB)

Dan,

Thanks for conducting this interview.

Can you comment on the Business Week article's conclusion that "the focus on protein could give CVBT an advantage"? Do you see that as your competitive advantage relative to others in your space?

Thanks,
David